Sino Biological

Sino Biological is an internationally-recognized reagent supplier and contract research organization, headquartered in Beijing, China with subsidiaries in the United States and Europe. The company  specializes in recombinant protein production and antibody development. All of Sino Biological’s products are independently developed and produced, including 6,000+ recombinant proteins and 13,000+ antibodies. As a global leader in recombinant technology, Sino Biological has a core technology platform; its in-house developed mammalian cell-based recombinant expression system. This system employs a range of proprietary reagents and processes, enabling highly efficient production of antigens and antibodies.

Sino Biological is dedicated to virology and infectious disease research. The company’s SARS-CoV-2 antibodies and antigens have been widely used to manufacture rapid antigen and antibody tests, and many of them have received the Emergency Use Authorization from the FDA. Sino Biological has developed the world’s largest recombinant viral antigen bank, ProVir™. This viral antigen collection has been used worldwide in infectious disease research, therapeutic antibody evaluation, immunodiagnostic assay and vaccine development.

For more information, please visit Sino Biological.